Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

LLLT is a safe, promising hair loss treatment, but more research needed.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Sophora flavescens extract may help hair grow by affecting growth factors and blocking a hair-related enzyme.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Endocrine therapies for cancer significantly increase the risk of hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.